menu search

Lifshitz law pllc announces investigations of apellis pharmaceutics, inc. (nasdaq: apls), rtx corp. (nyse: rtx), live nation entertainment, inc. (nyse: lyv), and keycorp (nyse: key)

NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) Lifshitz Law PLLC announces investigation into possible sec...

September 2, 2023, 11:00 pm

Nls pharmaceutics shares rise as narcolepsy treatment moves to phase 3 studies

Shares of NLS pharmaceutics Ltd. NLSP, +19.57% gained 12% premarket on Monday after the Swiss clinical-...

July 3, 2023, 8:53 am

Nls pharmaceutics company update and webcast today postponed

NLS to Webcast its Event on Thursday, July 6, 2023, at 11:00 am ET ZURICH, SWITERLAND / ACCESSWIRE / June 30, 2023 / NLS ...

June 30, 2023, 8:00 am

Correction from source: nls pharmaceutics to participate in the healthcare virtual conference presented by maxim group llc and hosted by m-vest

Presentation to take place on Tuesday, June 20, 2023, at 10:30AM ET ZURICH, SWITZERLAND / ACCESSWIRE / June 19, 2023 / NLS ...

June 19, 2023, 7:30 am

Nls pharmaceutics announces company update webcast

Members of Executive Leadership Team to Discuss initiation of Phase 3, Pipeline updates, Key Financials, Corporate Development, and the other topics N...

June 19, 2023, 7:10 am

Nls pharmaceutics announces company update webcast

Members of Executive Leadership Team to Discuss initiation of Phase 3, Pipeline updates, Key Financials, Corporate Development, and the other topics N...

June 15, 2023, 7:30 am

Eagle pharmaceuticals gets fda designations that will grant it extra exclusivity for bacterial pneumonia treatment

Eagle pharmaceutics Inc. EGRX said Wednesday it has won Food and Drug Administration Qualified Infectio...

June 14, 2023, 7:05 am

Yasheng group notifies finra of plan to pay preferred dividend to common shareholders

Begins Raising Capital for our Subsidiary, Jove pharmaceutics In Order to Bring Next Generation Cancer ...

March 1, 2023, 11:00 am

Skye bioscience says study shows enhanced reduction in intraocular pressure with its sbi-100 formulation for glaucoma

Skye Bioscience inc (OTCQB:SKYE) announced that the peer-reviewed journal International Journal of pharmaceuti...

May 5, 2022, 8:43 am

Nls pharma shares fall after mazindol er interim data shows 39% improvement on sleepiness scale

NLS pharmaceutics Ltd (NASDAQ: NLSP) has announced interim topline data from its Phase 2a trial of i...

March 16, 2022, 2:06 pm

Why are nls pharmaceutics shares trading higher during premarket monday?

NLS pharmaceutics Ltd NLSP shares are trading higher after the Company announced to present interim to...

February 7, 2022, 8:46 am

Why are nls pharmaceutics shares trading higher during premarket monday?

NLS pharmaceutics Ltd NLSP shares are trading higher after the Company announced to present interim to...

February 7, 2022, 8:46 am

Why are nls pharmaceutics shares trading higher during premarket monday?

NLS pharmaceutics Ltd NLSP shares are trading higher after the Company announced to present interim to...

February 7, 2022, 8:46 am

Nls pharmaceutics to present interim top-line data for quilience(r) (mazindol er) in patients with narcolepsy at the world sleep congress in march 2022

Phase 2a trial meets enrollment target for interim analysis and is now more than 50% enrolled 21 clinical sites in the United States actively enrollin...

February 7, 2022, 7:30 am

Nls pharmaceutics to present interim top-line data for quilience(r) (mazindol er) in patients with narcolepsy at the world sleep congress in march 2022

Phase 2a trial meets enrollment target for interim analysis and is now more than 50% enrolled 21 clinical sites in the United States actively enrollin...

February 7, 2022, 7:30 am

Nls pharmaceutics to present interim top-line data for quilience(r) (mazindol er) in patients with narcolepsy at the world sleep congress in march 2022

Phase 2a trial meets enrollment target for interim analysis and is now more than 50% enrolled 21 clinical sites in the United States actively enrollin...

February 7, 2022, 7:30 am

Catalent (ctlt) to advance oral drug development with new launch

Catalent's (CTLT) Xpress pharmaceutics service offers a quicker alternative to the traditional clinical...

January 20, 2022, 9:59 am

Catalent (ctlt) to advance oral drug development with new launch

Catalent's (CTLT) Xpress pharmaceutics service offers a quicker alternative to the traditional clinical...

January 20, 2022, 9:59 am

Catalent (ctlt) to advance oral drug development with new launch

Catalent's (CTLT) Xpress pharmaceutics service offers a quicker alternative to the traditional clinical...

January 20, 2022, 9:59 am


Search within

Pages Search Results: